Concomitant interferon-α therapy and tumor necrosis factor α inhibition for rheumatoid arthritis and hepatitis C

Arthritis and Rheumatism

Volumn 54, Issue 7, 2006, Pages 2335-2337

  Niewold, Timothy B ^a   Gibofsky, Allan ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; ETANERCEPT; LIVER ENZYME; METHYLPREDNISOLONE; NAPROXEN; PREDNISONE; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ARTICLE; CASE REPORT; DRUG SAFETY; FATIGUE; HEPATITIS C; HUMAN; JOINT EFFUSION; MALAISE; MALE; MYALGIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIVIRAL AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; HEPATITIS C; HUMANS; IMMUNOGLOBULIN G; INTERFERON-ALPHA; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; RIBAVIRIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745909426     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21949     Document Type: Article

References (9)

1. Mok MY, Ng WL, Yuen MF, Wong RW, Lau CS. Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis. Clin Exp Rheumatol 2000;18:363-8.
2. Calabrese LH, Zein N, Vassilopoulos D. Safety of antitumor necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection. Ann Rheum Dis 2004;63:S18-24.
3. Zein NN, and the Etanercept Study Group. Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study. J Hepatol 2005;42:315-22.
4. Ioannou Y, Isenberg DA. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy [review]. Arthritis Rheum 2000;43:1431-42.
5. Shiozawa S, Shiozawa K, Kita M, Kishida T, Fujita T, Imura S. A preliminary study on the effect of α-interferon treatment on the joint inflammation and serum calcium in rheumatoid arthritis. Br J Rheumatol 1992;31:405-8.
6. Wong T, Majchrzak B, Bogoch E, Keystone EC, Fish EN. Therapeutic implications for interferon-α in arthritis: a pilot study. J Rheumatol 2003;30:934-40.
7. Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J. Cross-regulation of TNF and IFN-α in autoimmune diseases. Proc Natl Acad Sci U S A 2005;102:3372-7.
8. Gonzalez-Amaro R, Garcia-Monzon C, Garcia-Buey L, Moreno-Otero R, Alonso JL, Yague E, et al. Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994;179:841-8.
9. Nelson DR, Lim HL, Marousis CG, Fang JW, Davis G, Shen L, et al. Activation of tumor necrosis factor-α system in chronic hepatitis C virus infection. Dig Dis Sci 1997;42:2487-94.